Melanoma SK-Mel-103 cell line : control vs. treated with pIC/pIC+PEI
收藏官方服务：
资源简介：
Melanoma SK-Mel-103 cell line : control vs. treated with pIC/pIC+PEI
应用场景：
创建时间：
2010-04-08
相关数据集
Hs 294T Cells Treated with Elesclomol Alone or in Combination with NAC Compared to DMSO Treated
We used microarrays to detail gene expression changes in Hs 294T human melanoma cells after treatment with elesclomol alone, or in combination with NAC, to aide in identifing the mechnism of action of
NIAID Data Ecosystem60
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq]
RNA-seq was performed to compare the transcriptional programmes of A375 cells treated with Palbociclib or GSK3326595 compared to untreated cells Cyclin dependent kinase 4/6 (CDK4/6) inhibitors are an
NIAID Data Ecosystem50
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
Metastatic melanoma patients carrying a BRAFV600 mutation can be treated with a combination of BRAF and MEK inhibitors (BRAFi/MEKi), but innate and acquired resistance invariably occurs. Predicting pa
NIAID Data Ecosystem40
DataSheet1_β-elemene Isopropanolamine Derivative LXX-8250 Induces Apoptosis Through Impairing Autophagic Flux via PFKFB4 Repression in Melanoma Cells.docx
Melanoma is a highly aggressive skin cancer and accounts for most of the skin cancer-related deaths. The efficacy of current therapies for melanoma remains to be improved. The isopropanolamine derivat
NIAID Data Ecosystem60
A novel Chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
Melanoma is one of the most aggressive tumors with the remarkable characteristic of resistance to traditional chemotherapy and radiotherapy. Although targeted therapy and immunotherapy benefit advance
NIAID Data Ecosystem40
